Kaposi 肉瘤

Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000 Apr 6;342(14):1027-38.

• 全文
• 摘要

Gallafent JH, Buskin SE, De Turk PB, et al. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol. 2005 Feb 20;23(6):1253-60.

• 全文
• 摘要

Department of Health and Human Services panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Mar 2018 [internet publication].

• 全文

Patel RM, Goldblum JR, Hsi ED. Immunohistochemical detection of human herpesvirus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Mod Pathol. 2004 Apr;17(4):456-60.

• 全文
• 摘要

Gbabe OF, Okwundu CI, Dedicoat M, et al. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database Syst Rev. 2014;(9):CD003256.

• 全文
• 摘要

National Cancer Institute: drugs approved for Kaposi sarcoma

1.  Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994 Dec 16;266(5192):1865-9.

• 摘要

2.  Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000 Apr 6;342(14):1027-38.

• 全文
• 摘要

3.  Geddes M, Franceschi S, Barchielli A, et al. Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer. 1994 Feb;69(2):333-6.

• 摘要

4.  Guttman-Yassky E, Bar-Chana M, Yukelson A, et al. Epidemiology of classic Kaposi's sarcoma in the Israeli Jewish population between 1960 and 1998. Br J Cancer. 2003 Nov 3;89(9):1657-60.

• 全文
• 摘要

5.  Mbulaiteye SM, Engels EA. Kaposi's sarcoma risk among transplant recipients in the United States (1993-2003). Int J Cancer. 2006 Dec 1;119(11):2685-91.

• 全文
• 摘要

6.  Hosseini-Moghaddam SM, Soleimanirahbar A, Mazzulli T, et al. Post renal transplantation Kaposi's sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy. Transpl Infect Dis. 2012 Aug;14(4):338-45.

• 摘要

7.  Cook-Mozaffari P, Newton R, Beral V, et al. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer. 1998 Dec;78(11):1521-8.

• 摘要

8.  Engels EA, Pfeiffer RM, Goedert JJ, et al; HIV/AIDS Cancer Match Study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006 Aug 1;20(12):1645-54.

• 摘要

9.  Eltom MA, Jemal A, Mbulaiteye SM, et al. Trends in Kaposi's sarcoma and non-Hodgkins lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002 Aug 21;94(16):1204-10.

• 摘要

10.  Douglas JL, Gustin JK, Dezub BJ, et al. Kaposi's sarcoma: a model of both malignancy and chronic inflammation. Panminerva Medica. 2007 Sep;49(3):119-38.

• 摘要

11.  Pantanowitz L, Früh K, Marconi S, et al. Pathology of rituximab-induced Kaposi sarcoma flare. BMC Clin Pathol. 2008 Jul 23;8:7.

• 全文
• 摘要

12.  Gallafent JH, Buskin SE, De Turk PB, et al. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol. 2005 Feb 20;23(6):1253-60.

• 全文
• 摘要

13.  Sullivan RJ, Pantanowitz L, Casper C, et al. HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis. 2008 Nov 1;47(9):1209-15.

• 全文
• 摘要

14.  Dezube BJ, Pantanowitz L, Aboulafia DM. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment. AIDS Read. 2004 May;14(5):236-8.

• 摘要

15.  Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, et al. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol. 2007 Feb;8(2):167-76.

• 摘要

16.  Department of Health and Human Services panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Mar 2018 [internet publication].

• 全文

17.  Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013 Feb;137(2):289-94.

• 全文
• 摘要

18.  Cheuk W, Wong KO, Wong CS, et al. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol. 2004 Mar;121(3):335-42.

• 摘要

19.  Patel RM, Goldblum JR, Hsi ED. Immunohistochemical detection of human herpesvirus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Mod Pathol. 2004 Apr;17(4):456-60.

• 全文
• 摘要

20.  Pitchenik AE, Fischl MA, Saldana MJ. Kaposi's sarcoma of the tracheobronchial tree. Clinical, bronchoscopic, and pathologic features. Chest. 1985 Jan;87(1):122-4.

• 摘要

21.  Zibrak JD, Silvestri RC, Costello P, et al. Bronchoscopic and radiologic features of Kaposi's sarcoma involving the respiratory system. Chest. 1986 Oct;90(4):476-9.

• 摘要

22.  Kodra A, Walczyszyn M, Grossman C, et al. Case report: pulmonary Kaposi sarcoma in a non-HIV patient. F1000Res. 2015 Oct 7;4:1013.

• 全文
• 摘要

23.  Casper C, Krantz E, Taylor H, et al. Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection. J Clin Microbiol. 2002 Oct;40(10):3822-5.

• 全文
• 摘要

24.  Caponetti G, Dezube BJ, Restrepo C, et al. Kaposi sarcoma of the musculoskeletal system: a review of 66 patients. Cancer. 2007 Mar 15;109(6):1040-52.

• 全文
• 摘要

25.  Wang J, Stebbing J, Bower M. HIV-associated Kaposi sarcoma and gender. Gend Med. 2007 Sep;4(3):266-73.

• 摘要

26.  Morooka M, Ito K, Kubota K, et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography images before and after chemotherapy for Kaposi sarcoma and highly active antiretrovirus therapy. Jpn J Radiol. 2010 Dec;28(10):759-62.

• 摘要

27.  Pantanowitz L, Dezube BJ, Pinkus GS, et al. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Cutan Pathol. 2004;31:26-34.

• 摘要

28.  Purgina B, Rao UN, Miettinen M, et al. AIDS-related EBV-associated smooth muscle tumors: a review of 64 published cases. Patholog Res Int. 2011;2011:561548.

• 全文
• 摘要

29.  Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol. 1989 Sep;7(9):1201-7.

• 摘要

30.  Nasti G, Talamini R, Antinori A, et al. AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS clinical trial group staging system in the HAART era - the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naïve From Antiretrovirals. J Clin Oncol. 2003 Aug 1;21(15):2876-82.

• 摘要

31.  Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, ed. Evaluation of chemotherapeutic agents. New York, NY: Columbia University Press; 1949:196.

32.  Brambilla L, Boneschi V, Taglioni M, et al. Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices. Eur J Dermatol. 2003 Jan-Feb;13(1):83-6.

• 摘要

33.  Pantanowitz L, Dezube BJ. Advances in the pathobiology and treatment of Kaposi sarcoma. Curr Opin Oncol. 2004;16:443-449.

• 摘要

34.  Kutlubay Z, Küçüktaş M, Yardimci G, et al. Evaluation of effectiveness of cryotherapy on the treatment of cutaneous Kaposi's sarcoma. Dermatol Surg. 2013 Oct;39(10):1502-6.

• 摘要

35.  Caccialanza M, Marca S, Piccinno R, et al. Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: results in 1482 lesions. J Eur Acad Dermatol Venereol. 2008 Mar;22(3):297-302.

• 摘要

36.  Krown SE, Northfelt DW, Osoba D, et al. Use of liposomal anthracyclines in Kaposi's sarcoma. Semin Oncol. 2004 Dec;31(6 suppl 13):36-52.

• 摘要

37.  Gill PS, Wernz J, Scadden DT, et al. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol. 1996 Aug;14(8):2353-64.

• 摘要

38.  Raimundo KP, Asche CV. A review of the efficacy and outcomes studies of currently approved chemotherapy treatments for advanced AIDS-Kaposi's sarcoma. HIV AIDS Rev. 2011;10:56-60.

39.  Dhillon T, Stebbing J, Bower M. Paclitaxel for AIDS-associated Kaposi's sarcoma. Expert Rev Anticancer Ther. 2005 Apr;5(2):215-9.

• 摘要

40.  Gill PS, Tulpule A, Espina BM, et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 1999 Jun;17(6):1876-83.

• 摘要

41.  Nasti G, Errante D, Talamini R, et al. Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study. J Clin Oncol. 2000 Apr;18(7):1550-7.

• 摘要

42.  Krueter A, Rasokat H, Klouche N, et al. Liposomal pegylated doxorubicin versus low-dose recombinant interferon alfa-2a in the treatment of advanced classic Kaposi's sarcoma: retrospective analysis of three German centers. Cancer Invest. 2005;23(8):653-9.

• 摘要

43.  Krown SE, Li P, Von Roenn JH, et al. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study. J Interferon Cytokine Res. 2002 Mar;22(3):295-303.

• 摘要

44.  Evans SR, Krown SE, Testa MA, et al. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study. J Clin Oncol. 2002 Aug 1;20(15):3236-41.

• 摘要

45.  Strother RM, Gregory KM, Pastakia SD, et al. Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi's sarcoma in western Kenya. Oncology. 2010;78(1):5-11.

• 全文
• 摘要

46.  Brambilla L, Recalcati S, Tourlaki A. Vinorelbine therapy in classic Kaposi's sarcoma: a retrospective study of 20 patients. Eur J Dermatol. 2015 Nov-Dec;25(6):535-8.

• 摘要

47.  Tas F, Sen F, Keskin S, et al. Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS). J Eur Acad Dermatol Venereol. 2013 Jun;27(6):789-92.

• 摘要

48.  Brambilla L, Labianca R, Ferrucci SM, et al. Treatment of classical Kaposi's sarcoma with gemcitabine. Dermatology. 2001;202(2):119-22.

• 摘要

49.  Tur E, Brenner S, Michalevicz R. Low dose recombinant interferon alfa treatment for classic Kaposi's sarcoma. Arch Dermatol. 1993 Oct;129(10):1297-300.

• 摘要

50.  Costa da Cunha CS, Lebbe C, Rybojad M, et al. Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b. Arch Dermatol. 1996 Mar;132(3):285-90.

• 摘要

51.  World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach - second edition, 2016. Jun 2016 [internet publication].

• 全文

52.  Bower M, Dalla Pria A, Coyle C, et al. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma. J Clin Oncol. 2014 Feb 10;32(5):409-14.

• 摘要

53.  Gbabe OF, Okwundu CI, Dedicoat M, et al. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database Syst Rev. 2014;(9):CD003256.

• 全文
• 摘要

54.  Shepherd FA, Maher E, Cardella C, et al. Treatment of Kaposi's sarcoma after solid organ transplantation. J Clin Oncol. 1997 Jun;15(6):2371-7.

• 摘要

55.  Lebbé C, Euvrard S, Barrou B, et al. Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant. 2006 Sep;6(9):2164-8.

• 全文
• 摘要

56.  Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Mar 2018 [internet publication].

• 全文

57.  Bodsworth NJ, Bloch M, Bower M, et al; International Panretin Gel KS Study Group. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma. Am J Clin Dermatol. 2001;2(2):77-87.

• 摘要

58.  Epstein JB. Treatment of oral Kaposi sarcoma with intralesional vinblastine. Cancer. 1993 Mar 1;71(5):1722-5.

• 摘要

59.  Stein ME, Spencer D, Ruff P, et al. Endemic African Kaposi sarcoma: clinical and therapeutic implications. 10-year experience in the Johannesburg Hospital (1980-1990). Oncology. 1994 Jan-Feb;51(1):63-9.

• 摘要

60.  Little RF, Wyvill KM, Pluda JM, et al. Activity of thalidomide in AIDS-related Kaposi's sarcoma. J Clin Oncol. 2000 Jul;18(13):2593-602.

• 摘要

61.  Dezube BJ, Von Roenn JH, Holden-Wiltse J, et al. Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. J Clin Oncol. 1998 Apr;16(4):1444-9.

• 摘要

62.  Dezube BJ, Krown SE, Lee JY, et al. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol. 2006 Mar 20;24(9):1389-94.

• 全文
• 摘要

63.  Koon HB, Bubley GJ, Pantanowitz L, et al. Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J Clin Oncol. 2005 Feb 10;23(5):982-9.

• 全文
• 摘要

64.  Uldrick TS, Wyvill KM, Kumar P, et al. Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. J Clin Oncol. 2012 May 1;30(13):1476-83.

• 全文
• 摘要

65.  Wang X, Bao Z, Zhang X, et al. Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis. Oncotarget. 2017 May 31;8(35):59901-14.

• 全文
• 摘要

66.  ClinicalTrials.gov. Phase II multicentric study of pembrolizumab in classic or endemic Kaposi's sarcoma (KAPKEY). Mar 2018 [internet publication].

• 全文

67.  Krown SE, Roy D, Lee JY, et al. Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):447-54.

• 全文
• 摘要

68.  Polizzotto MN, Uldrick TS, Wyvill KM, et al. Pomalidomide for symptomatic Kaposi's sarcoma in people with and without HIV infection: a phase I/II study. J Clin Oncol. 2016 Dec;34(34):4125-31.

• 全文
• 摘要

69.  ClinicalTrials.gov. Pomalidomide in combination with liposomal doxorubicin in people with advanced or refractory Kaposi sarcoma. Nov 2017 [internet publication].

• 全文

70.  ClinicalTrials.gov. sEphB4-HSA in treating patients with Kaposi sarcoma. Mar 2018 [internet publication].

• 全文

71.  Miles SA, Dezube BJ, Lee JY, et al; AIDS Malignancy Consortium. Antitumor activity of oral 9-cis-Retinoic acid in HIV-associated Kaposi's sarcoma. AIDS. 2002 Feb 15;16(3):421-9.

• 摘要

72.  Aboulafia DM, Norris D, Henry D, et al. 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial. Arch Dermatol. 2003 Feb;139(2):178-86.

• 摘要

73.  Little RF, Pluda JM, Wyvill KM, et al. Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood. 2006 Jun 15;107(12):4650-7.

• 全文
• 摘要

74.  Little RF, Aleman K, Kumar P, et al. Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma. Blood. 2007 Dec 15;110(13):4165-71.

• 全文
• 摘要

75.  Gill PS, Lunardi-Ishkandar Y, Louie S, et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med. 1996 Oct 24;335(17):1261-9.

• 全文
• 摘要

76.  Gill PS, McLaughlin T, Espina BM, et al. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J Natl Cancer Inst. 1997 Dec 3;89(23):1797-802.

• 摘要

77.  ClinicalTrials.gov. Nelfinavir mesylate in treating patients with Kaposi sarcoma. Apr 2018 [internet publication].

• 全文

78.  Feller L, Masipa J, Wood N, et al. The prognostic significance of facial lymphoedema in HIV-seropositive subjects with Kaposi sarcoma. AIDS Res Ther. 2008;5:2.

• 全文
• 摘要

79.  Pantanowitz L, Dezube BJ. AIDS-associated Kaposi sarcoma of the larynx. AIDS Read. 2006;16:194-195.

• 摘要

80.  Portsmouth S, Stebbing J, Gill J, et al. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS. 2003 Jul 25;17(11):F17-22.

• 摘要